Eight new anticonvulsant medications have been approved in the United States since 1993, offering physicians a greater range of options for treating children with partial and generalized seizures. However, pediatric neurologists have been faced with limited pediatric pharmacokinetic and pharmacodynamic information. This article reviews the newer antiepilepsy drugs—gabapentin, felbamate, lamotrigine, topiramate, oxcarbazepine, levetiracetam, and zonisamide—and summarizes what is currently known about the safety and efficacy of these drugs in treating partial and generalized seizures in the pediatric population. Further studies are needed, however, to thoroughly evaluate their efficacy and safety in children. (J Child Neurol 2002;17:S65—S69).
References
1.
Annegers JF: The epidemiology of epilepsy, in Wyllie E (ed): The Treatment of Epilepsy, 3rd ed. Philadelphia, Lippincott Williams and Wilkins, 2001, 131—138.
2.
Arunkumar G., Kotogal P., Rothner D.: Localization-related epilepsies: Simple partial seizures, complex partial seizures, benign focal epilepsy of childhood and epilepsia partialis continua , in Pellock J, Dodson EW, Bourgeois BF (eds): Pediatric Epilepsy Diagnosis and Therapy. New York, Raven, 2001, 243—264.
3.
Guerreiro MM , Vigonius U., Pohlmann H., et al: A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy . Epilepsy Res1997;27: 205—213.
4.
Sachdeo RC, Edwards K., Hasegawa H., et al: Safety and efficacy of oxcarbazepine 1200 mg/day in patients with refractory partial seizures, abstract. Neurology1999;52(Suppl 2):A391.
5.
Schachter SC, Vazquez B., Fisher RS, et al: Oxcarbazepine: A double blind, randomized, placebo-control, monotherapy trial in patients with epilepsy after presurgical evaluation of refractory partial seizures. Neurology1999 ;52:732—737.
6.
Beydoun A., Sachdeo RC, Rosenfeld WE, et al: Oxcarbazepine monotherapy for partial-onset seizures: A multicenter, double-blind, clinical trial. Neurology2000 ;54:2245—2251.
7.
Glauser TA, Nigro M., Sachdeo R., et al: Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology2000;54: 2237—2244.
8.
Appleton R., Fichtner K., LaMoreaux L., et al: Gabapentin as add-on therapy in children with refractory partial seizures: A 12-week, multicenter, double-blind, placebo-controlled study. Epilepsia1999;40:1147—1154.
9.
Bourgeois B. , Brown LW, Pellock JM, et al: Gabapentin (Neuron-tin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): A 36-week, double-blind, placebo-controlled study, abstract. Epilepsia1998;39(Suppl 6):S163.
10.
Glauser TA: Expanding first-line therapy options for children with partial seizures. Neurology2000;55(Suppl 3):S30—S37.
11.
Holmes GL: Gabapentin for treatment of epilepsy in children. Semin Pediatr Neurol1997;4:244—250.
12.
Lee D., Steingard R., Cesena M., et al: Behavioral side effects of gabapentin in children. Epilepsia1996;37:87—90.
13.
Duchowny M. , Pellock JM, Graf WD, et al: A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology1999;53:1724—1731.
Lombroso C. : Lamotrigine induced tourettism. Neurology1999;52: 1191—1194.
16.
Dooley J., Camfield O., Gordon K., et al: Lamotrigine induced rash in children. Neurology1996;46:240—242.
17.
Guberman A. , Besag F., Brodie M., et al: Lamotrigine associated rash: Risk benefit ratio considerations in adults and children. Epilepsia1999;40:985—996.
Gilliam FG, Reife R., Wu S-C.: Topiramate monotherapy: Randomized controlled trial in patients with recently diagnosed localization-related epilepsy, abstract. Neurology1999;52(Suppl 2):A248.
20.
Elterman RD , Glauser TA, Wyllie E., et al: A double-blind, randomized trial of topiramate as adjunctive therapy for partial onset seizures in children. Neurology1999;52:1338—1344.
21.
Bourgeois B. : New antiepileptic drugs in children: Which ones for which seizures?Clin Neuropharmacol2000;23:119—132.
22.
Pellock JM, Glauser TA, Bebin EM, et al: Pharmacokinetic study of levetiracetam in children. Epilepsia2001; in press.
23.
Glauser TA, Pellock JM, Bebin EM, et al: Efficacy and safety of levetiracetam with partial seizures: An open label trial. Submitted.
24.
Ojemann LM, Shastri RA, Wilensky AJ, et al: Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine and phenytoin monotherapy. Ther Drug Monit1986;8: 293—296.
25.
Kumagai N., Seki T., Yamawaki H., et al: Monotherapy for childhood epilepsies with zonisamide. Jpn J Psychiatr Neurol1991;45: 357—359.
26.
Frank LM, Enlow T., Holmes GL, et al: Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia1999;40:973—979.
27.
Cross JH: Topiramate monotherapy for children with absence seizures: Results from an open-label pilot study. Epilepsia1998;39(Suppl6):164.
28.
Code of Federal Regulations. 21 CFR section 201.57. Available at: http://www.access.gpo.gov/nara/cfr/waisidx_01/21cfr201_01.html . Accessed Dec 26, 2001.
29.
Section 505A of the Food and Drug Administration Modernization Act; The Pediatric Exclusivity Provision. Available at: www.fda.gov/opacom/7modact.com. Accessed Dec 26, 2001.
30.
The Pediatric Exclusivity Provision January 2001Report, Status Report to Congress. Department of Health and Human Services, US Food and Drug Administration. Available at: http://www.fda.gov/cder/pediatric/reportcong01.pdf . Accessed Dec 26, 2001.
31.
Code of Federal Regulations Part 201,312,314,601. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients: Final Rule. Available at: http://www.access.gpo.gov/cgi-bin/cfrassemble.cgi?title=200121 . Accessed Dec 26, 2001.
